Follow-up lab work is scheduled 90 days after to ensure your levels are optimized
Initiating estrogen therapy earlier in the menopausal transition, typically within 10 years of the final menstrual period and before age 60, is associated with a more favorable cardiovascular profile [26]
For individuals navigating these challenges, treating hormonal weight gain in a thoughtful way means addressing the full picture: hormones, lifestyle, and metabolism together
Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration
Microdoses take longer but feel gentler
However, in addition to this, these hormones can also influence bone turnover by directly, or indirectly, modulating the activity of osteoblast and osteoclast cells